Controversy still simmers over plan to build plasma-fractionation plant in Nova Scotia.
Controversy still simmers over a plan by the Canadian Red Cross Society and a US biopharmaceutical manufacturer to build a plasma-fractionation plant near Halifax. The unilateral decision to go ahead with the plant was taken as the Krever inquiry into Canada's blood-supply system was holding public hearings across the country. A panel created to evaluate the proposal has supported the fractionation plant, but made additional recommendations concerning product pricing, research and development, plasmapheresis centres and membership of the Board of Directors.
Robb
N
N
D005591:Chemical Fractionation; D004345:Drug Industry; D006801:Humans; D007373:Interinstitutional Relations; D009674:Nova Scotia; D010949:Plasma; D012011:Red Cross